175 related articles for article (PubMed ID: 33099810)
1. Prevalence of inflammatory bowel disease among pediatric patients with hidradenitis suppurativa and the potential role of screening with fecal calprotectin.
Lloyd-McLennan AM; Ali S; Kittler NW
Pediatr Dermatol; 2021 Jan; 38(1):98-102. PubMed ID: 33099810
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
Yang Z; Clark N; Park KT
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease.
Henderson P; Casey A; Lawrence SJ; Kennedy NA; Kingstone K; Rogers P; Gillett PM; Wilson DC
Am J Gastroenterol; 2012 Jun; 107(6):941-9. PubMed ID: 22370604
[TBL] [Abstract][Full Text] [Related]
4. Hidradenitis suppurativa and inflammatory bowel disease in a nested case-control study.
Neri B; Mossa M; Salvatori S; Appolloni V; Pensa C; Lambiase S; Lolli E; Calabrese E; Monteleone G; Bianchi L; Campione E; Biancone L
Dig Liver Dis; 2023 Apr; 55(4):490-495. PubMed ID: 36371384
[TBL] [Abstract][Full Text] [Related]
5. Causal association between inflammatory bowel disease and hidradenitis suppurativa: A two-sample bidirectional Mendelian randomization study.
Bao B; Zhu C; Shi J; Lu C
Front Immunol; 2023; 14():1071616. PubMed ID: 36776852
[TBL] [Abstract][Full Text] [Related]
6. Anemia and Systemic Inflammatory Markers in Patients with Perianal Disease: Hidradenitis Suppurativa and Inflammatory Bowel Disease.
Yamanaka-Takaichi M; Raffals LE; Ehman EC; Loftus EV; Alavi A
Dermatology; 2023; 239(5):843-848. PubMed ID: 37356426
[TBL] [Abstract][Full Text] [Related]
7. The in-hospital burden of hidradenitis suppurativa in patients with inflammatory bowel disease: a decade nationwide analysis from 2004 to 2014.
Ramos-Rodriguez AJ; Timerman D; Khan A; Bonomo L; Hunjan MK; Lemor A
Int J Dermatol; 2018 May; 57(5):547-552. PubMed ID: 29431201
[TBL] [Abstract][Full Text] [Related]
8. Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota.
Yadav S; Singh S; Edakkanambeth Varayil J; Harmsen WS; Zinsmeister AR; Tremaine WJ; Davis MD; Wetter DA; Colombel JF; Loftus EV
Clin Gastroenterol Hepatol; 2016 Jan; 14(1):65-70. PubMed ID: 25952308
[TBL] [Abstract][Full Text] [Related]
9. Fecal Calprotectin to Detect Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis.
Ferrara G; Pastore S; Sancin L; Torelli L; Radillo O; Bramuzzo M; Bibalo C; Tommasini A; Ventura A; Taddio A
J Rheumatol; 2018 Oct; 45(10):1418-1421. PubMed ID: 29907671
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis.
Henderson P; Anderson NH; Wilson DC
Am J Gastroenterol; 2014 May; 109(5):637-45. PubMed ID: 23670113
[TBL] [Abstract][Full Text] [Related]
11. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.
Sidler MA; Leach ST; Day AS
Inflamm Bowel Dis; 2008 Mar; 14(3):359-66. PubMed ID: 18050298
[TBL] [Abstract][Full Text] [Related]
12. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of inflammatory bowel disease (IBD) in hidradenitis suppurativa (HS): systematic review and adjusted meta-analysis.
Phan K; Tatian A; Woods J; Cains G; Frew JW
Int J Dermatol; 2020 Feb; 59(2):221-228. PubMed ID: 31631340
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study.
Deckers IE; Benhadou F; Koldijk MJ; Del Marmol V; Horváth B; Boer J; van der Zee HH; Prens EP
J Am Acad Dermatol; 2017 Jan; 76(1):49-53. PubMed ID: 27793450
[TBL] [Abstract][Full Text] [Related]
15. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.
Hoekman DR; Diederen K; Koot BG; Tabbers MM; Kindermann A; Benninga MA
Eur J Pediatr; 2016 Oct; 175(10):1335-42. PubMed ID: 27573259
[TBL] [Abstract][Full Text] [Related]
16. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive testing in the management of children with suspected inflammatory bowel disease.
Dilillo D; Zuccotti GV; Galli E; Meneghin F; Dell'Era A; Penagini F; Colella G; Lewindon P; Carmagnola S; Farina E; Ardizzone S; Maconi G
Scand J Gastroenterol; 2019 May; 54(5):586-591. PubMed ID: 31032665
[No Abstract] [Full Text] [Related]
18. Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care.
Conroy S; Hale MF; Cross SS; Swallow K; Sidhu RH; Sargur R; Lobo AJ
J Clin Pathol; 2018 Apr; 71(4):316-322. PubMed ID: 28844038
[TBL] [Abstract][Full Text] [Related]
19. A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease.
Lee JM; Jang JH; Ryu JH; Yoo J; Lee BI; Kim SJ; Oh EJ
PLoS One; 2021; 16(8):e0255974. PubMed ID: 34383847
[TBL] [Abstract][Full Text] [Related]
20. Comparison of fecal pyruvate kinase isoform M2 and calprotectin in assessment of pediatric inflammatory bowel disease severity and activity.
Czub E; Nowak JK; Szaflarska-Poplawska A; Grzybowska-Chlebowczyk U; Landowski P; Moczko J; Adamczak D; Mankowski P; Banasiewicz T; Plawski A; Walkowiak J
Acta Biochim Pol; 2014; 61(1):99-102. PubMed ID: 24649481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
